We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Self-Powered Implant Short-Circuits Hunger Pangs

By HospiMedica International staff writers
Posted on 02 Jan 2019
A new study describes how a battery-free implanted device gently stimulates vagal afferent fibers to reduce food intake and achieve weight control.

Developed by researchers at the University of Wisconsin (WISC; Madison, USA) and the University of Electronic Science and Technology of China (Chengdu, China), the vagus nerve stimulation system is comprised of a flexible, biocompatible, battery-free nanogenerator that is attached to the surface of stomach, generating biphasic electric pulses in response to gastric peristalsis. More...
The electric signals generated by the device stimulate vagus nerve afferent fibers in order to reduce food intake and realize weight control.

In a rat model, the researchers achieved a 38% weight loss in just 15 days, which was maintained for a period of 100 days without rebound. When the researchers removed the devices after a period of 12 weeks, the rats resumed their normal eating patterns and their excess weight returned. A potential advantage of the new device over existing vagus nerve stimulators, according to the researchers, is that it is a smart, self-responsive system that does not require external charging. The study was published on December 17, 2018, in Nature Communications.

“The pulses correlate with the stomach's motions, enhancing a natural response to help control food intake. It's automatically responsive to our body function, producing stimulation when needed. Our body knows best,” said senior author professor of materials science and engineering Xudong Wang, PhD, of WISC. “Our expectation is that the device will be more effective and convenient to use than other technologies.”

It has been known for a century that the vagus (tenth cranial) nerve, a mixed parasympathetic nerve containing both afferent and efferent nerve fibers, acts as a signal bridge to transport information between the central nervous system and the body. Neuromodulation, as a non-destructive, reversible therapeutic strategy, can manipulate body functions by stimulating or influencing neurophysiological signals through the neural networks to achieve therapeutic purpose.

Related Links:
University of Wisconsin
University of Electronic Science and Technology of China


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.